Skip to main content Skip to main navigation menu Skip to site footer
Articles
Published: 2025-02-28

Serological insights and clinical patterns of dengue fever in a tertiary care hospital: a survey-based study

Central Council for Research in Unani Medicine, New Delhi, India
##plugins.generic.jatsParser.article.authorBio##
×

Zikra Tahseen

Dr. Zikra Tahseen A

B.U.M.S., M.D.(Ilm ul advia)

Research Officer (Unani) Scientist Level-1

Central Council for Research in Unani Medicine, New Delhi, India

Central Council for Research in Unani Medicine, New Delhi, India
Dengue, Paediatric Case, ELISA, Clinical Manifestation, Positivity Trends, India

Abstract

Background: Dengue fever, a vector-borne disease caused by the dengue virus (DENV) and transmitted by Aedes mosquitoes, remains a public health concern in India, especially due to its seasonal and geographical variability. The disease manifests with symptoms like fever, myalgia, rashes, leukopenia, and thrombocytopenia, affecting various organs. This study aimed to examine the demographic patterns, clinical presentations, and healthcare-seeking behavior of paediatric dengue patients. Additionally, it analyzed dengue positivity trends from 2021 to 2023.

Methods: A descriptive cross-sectional study was conducted from September to December 2021 among suspected dengue paediatric patients admitted to the Paediatrics department of Autonomous State Medical College Firozabad. Diagnostic tests included Dengue rapid NS1, ELISA NS1 Antigen, and IgM ELISA. Data were analyzed to assess clinical symptoms, healthcare access, and yearly dengue trends.

Results: A total of 6,445 patients were clinically suspected of dengue at the Paediatrics IPD, Autonomous State Medical College, Firozabad, Uttar Pradesh. Among them, 386 were confirmed dengue-positive by rapid card, NS1 antigen, or IgM ELISA tests. The highest number of suspected cases (43.17%) was observed in school-going children (6–12 years). Males (55.47%) were more affected than females (44.53%), with nearly equal distribution between rural and urban areas. Platelet counts varied widely, with 31.73% having counts between 50,000–100,000. Fever with myalgia (75.65%) was the most common symptom. Dengue positivity fluctuated across years, with the highest rate in 2021 (193/1147 cases), followed by declines in 2022 and 2023.

Conclusion: Dengue fever shows a variable trend in incidence, with significant impact from healthcare access and public awareness. Improving awareness and timely diagnosis could help mitigate the severity of cases in future outbreaks.



Downloads

Download data is not yet available.

References

  1. Harrison TR. Principles of Internal Medicine. 17th ed. Toronto: McGraw Hill Education; 2008. Vol 1, p. 750, 764, 1230.
  2. Gubler DJ. Current research on dengue. 1987;3:37–56.
  3. Hasan S, Jamdar SF, Alalowi M. Dengue virus: A global human threat: Review of literature. 2016;1–6.
  4. Gupta A, Rijhwani P, Pahadia MR, Kalia A, Choudhary S, Bansal DP, et al. Prevalence of dengue serotypes and its correlation with the laboratory profile at a tertiary care hospital in northwestern India. Cureus. 2021;13(5):e14852.
  5. Dussart P, Duong V, Bleakley K, Fortas C, Try PL, Kim KS, et al. Comparison of dengue case classification schemes and evaluation of biological changes in different dengue clinical patterns in a longitudinal follow-up of hospitalized children in Cambodia. PLoS Negl Trop Dis [Internet]. 2020;14(9):e0008603. Available from: http://dx.doi.org/10.1371/journal.pntd.0008603
  6. James W, Elston D, TJ et al. Operational guidelines for prevention and control of Aedes mosquitoes in hospital settings. Andrew’s Dis Ski Clin Dermatology. 20AD.
  7. Bhattacharya MK, Maitra S, Ganguly A, Bhattacharya A, Sinha A. Dengue: A growing menace—a snapshot of recent facts, figures, and remedies. Int J Biomed Sci. 2013;9(2):61–7.
  8. National Center for Vector Borne Diseases Control, India. Dengue situation in India [Internet]. 2024. Available from: https://ncvbdc.mohfw.gov.in/index4.php?lang=1&level=0&linkid=431&lid=3715. Accessed 2024 Sep 22.
  9. Elling R, Henneke P, Hatz C, Hufnagel M. Dengue fever in children: Where are we now? Pediatr Infect Dis J. 2013;32(9):1020–2.
  10. de Souza LJ, Bastos Pessanha L, Carvalho Mansur L, Assed de Souza L, Barbosa Tâmega Ribeiro M, do Vale da Silveira M, et al. Comparison of clinical and laboratory characteristics between children and adults with dengue. Braz J Infect Dis [Internet]. 2013;17(1):27–31. Available from: http://dx.doi.org/10.1016/j.bjid.2012.08.020
  11. de Azeredo EL, Monteiro RQ, de-Oliveira Pinto LM. Thrombocytopenia in dengue: Interrelationship between virus and the imbalance between coagulation and fibrinolysis and inflammatory mediators. Mediators Inflamm. 2015;2015:313842.
  12. L OI, Emmanuel Ifeanyi O, Getrude Uzoma O, Doris A. The relationship between platelet count and hemoglobin level. Sch Acad J Biosci [Internet]. 2015;3(8):679–68. Available from: www.saspublisher.com
  13. Gupta B, Nehara H, Parmar S, Meena S, Gajraj S, Gupta J. Acute abdomen presentation in dengue fever during recent outbreak. J Acute Dis. 2017;6(5):198.
  14. Raafat N, Blacksell SD, Maude RJ. A review of dengue diagnostics and implications for surveillance and control. Trans R Soc Trop Med Hyg. 2019;113(11):653–60.
  15. Andries AC, Duong V, Cappelle J, Ong S, Kerleguer A, Ly S, et al. Proteinuria during dengue fever in children. Int J Infect Dis [Internet]. 2017;55:38–44. Available from: http://dx.doi.org/10.1016/j.ijid.2016.12.022


How to Cite

1.
Tahseen Z, Yadav C. Serological insights and clinical patterns of dengue fever in a tertiary care hospital: a survey-based study. J Ideas Health [Internet]. 2025 Feb. 28 [cited 2025 Mar. 17];8(1):1240-6. Available from: https://jidhealth.com/index.php/jidhealth/article/view/401